Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy

NCT: NCT06958848 · RECRUITING

NCT IDNCT06958848
StatusRECRUITING
Start Date2025-05-01
Completion2027-08-30

Brief Summary

The aim of the study is to evaluate postoperative pain in patients receiving a small-bore (16F) chest drain compared to those receiving the standard large-bore (24F) chest drain after minimally invasive pulmonary lobectomy and/or segmentectomy.

Frequently Asked Questions

What is 16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy?

16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy is a clinical trial registered under NCT06958848. Current status: RECRUITING.

What is the status of NCT06958848?

The current status of NCT06958848 (16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy) is: RECRUITING.

When did 16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy start?

16F vs 24F Chest Drain After Minimally Invasive Lobectomy and/or Segmentectomy started on 2025-05-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑